Biocon Limited (NSE:BIOCON)
India · Delayed Price · Currency is INR 384.90
-5.75 (-1.47%)
At close: Dec 16, 2025
Biocon Market Cap
Biocon has a market cap or net worth of 513.63 billion as of December 16, 2025. Its market cap has increased by 17.92% in one year.
Market Cap
513.63B
Enterprise Value
680.47B
Revenue
164.76B
Ranking
n/a
PE Ratio
98.55
Stock Price
384.90
Market Cap Chart
Since April 7, 2004, Biocon's market cap has increased from 45.41B to 513.63B, an increase of 1,031.03%. That is a compound annual growth rate of 11.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 16, 2025 | 513.63B | 17.47% |
| Dec 31, 2024 | 437.25B | 46.69% |
| Dec 29, 2023 | 298.08B | -4.59% |
| Dec 30, 2022 | 312.41B | -27.97% |
| Dec 31, 2021 | 433.73B | -21.37% |
| Dec 31, 2020 | 551.59B | 58.78% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.30T |
| Divi's Laboratories | 1.71T |
| Cipla | 1.23T |
| Apollo Hospitals Enterprise | 1.02T |
| Zydus Lifesciences | 934.94B |
| Mankind Pharma | 899.42B |
| Aurobindo Pharma | 694.12B |
| Alkem Laboratories | 673.27B |